San Diego-centered Viking Therapeutics marked by itself as a serious competitor while in the weight loss drug marketplace in February just after revealing promising details from the mid-phase trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when given to be a weekly injection As well as in Ma